A citation-based method for searching scientific literature

Mikhail Kosiborod. Endocrinol Metab Clin North Am 2018
Times Cited: 12







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study.
Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Milena Cecere, Susanna Mosca, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana,[...]. Diabetes Care 2018
18
25

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
25

Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
David Planer, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R Brodie, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W Stone. Int J Cardiol 2013
46
25

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Prakash Deedwania, Mikhail Kosiborod, Eugene Barrett, Antonio Ceriello, William Isley, Theodore Mazzone, Philip Raskin. Circulation 2008
306
25

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Hans Erik Bøtker, Won Yong Kim, Anders B Mathiasen, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen,[...]. Eur Heart J 2012
380
16

Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Wei Ren Chen, Shun Ying Hu, Yun Dai Chen, Ying Zhang, Geng Qian, Jing Wang, Jun Jie Yang, Zhi Feng Wang, Feng Tian, Qing Xiu Ning. Am Heart J 2015
67
16

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
Leo Timmers, José P S Henriques, Dominique P V de Kleijn, J Hans Devries, Hans Kemperman, Paul Steendijk, Cees W J Verlaan, Marjolein Kerver, Jan J Piek, Pieter A Doevendans,[...]. J Am Coll Cardiol 2009
345
16


High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia.
Vincent W Wong, Mahidi Mardini, N Wah Cheung, Anastasia S Mihailidou. J Diabetes Complications 2011
16
16

Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.
Guillermo E Umpierrez, Scott D Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M Thaler, Abbas E Kitabchi. J Clin Endocrinol Metab 2002
16

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
16

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.
Małgorzata Bartnik, Lars Rydén, Roberto Ferrari, Klas Malmberg, Kalevi Pyörälä, Maarten Simoons, Eberhard Standl, Jordi Soler-Soler, John Ohrvik. Eur Heart J 2004
422
16

Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
Dariush Mozaffarian, RosaMaria Marfisi, Giacomo Levantesi, Maria G Silletta, Luigi Tavazzi, Gianni Tognoni, Franco Valagussa, Roberto Marchioli. Lancet 2007
99
16


Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, Jose C Nicolau, Judith S Hochman, W Douglas Weaver, Pierre Theroux, Gustavo B F Oliveira, Thomas G Todaro, Christopher F Mojcik,[...]. Eur Heart J 2006
141
16

Glucose normalization and outcomes in patients with acute myocardial infarction.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Frederick A Masoudi, Abhinav Goyal, Lan Xiao, Philip G Jones, Suzanne Fiske, John A Spertus. Arch Intern Med 2009
87
16

U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.
Duane S Pinto, Adam H Skolnick, Ajay J Kirtane, Sabina A Murphy, Hal V Barron, Robert P Giugliano, Christopher P Cannon, Eugene Braunwald, C Michael Gibson. J Am Coll Cardiol 2005
123
16

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Ischa Stranders, Michaela Diamant, Rogier E van Gelder, Hugo J Spruijt, Jos W R Twisk, Robert J Heine, Frans C Visser. Arch Intern Med 2004
251
16

Reduced Cardio-Renal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
Giancarlo Marenzi, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Monica De Metrio, Maurizio Rondinelli, Stefano Cornara, Alberto Somaschini, Rita Camporotondo, Andrea Demarchi,[...]. Diabetes Care 2019
8
25

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome.
Edouard Gerbaud, Romain Darier, Michel Montaudon, Marie-Christine Beauvieux, Christine Coffin-Boutreux, Pierre Coste, Hervé Douard, Alexandre Ouattara, Bogdan Catargi. Diabetes Care 2019
43
16

Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.
Giancarlo Marenzi, Monica De Metrio, Mara Rubino, Gianfranco Lauri, Annalisa Cavallero, Emilio Assanelli, Marco Grazi, Marco Moltrasio, Ivana Marana, Jeness Campodonico,[...]. Am Heart J 2010
66
16


Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.
Mahmoud Suleiman, Haim Hammerman, Monther Boulos, Michael R Kapeliovich, Abeer Suleiman, Yoram Agmon, Walter Markiewicz, Doron Aronson. Circulation 2005
187
16

A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.
K Foo, J Cooper, A Deaner, C Knight, A Suliman, K Ranjadayalan, A D Timmis. Heart 2003
144
16

Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.
G A Oswald, C C Smith, D J Betteridge, J S Yudkin. Br Med J (Clin Res Ed) 1986
231
16

Prognostic Value of Hyperglycemia on Admission on In-hospital Outcomes in Patients Presenting with ST-elevation Myocardial Infarction.
Muhammad Shahid, Hafiz Muhammad Asif Zarif, Muhammad Shahzad Farid, Muhammad Shoaib Abid, Burhan Akhtar, Momin Rasheed Khan. Cureus 2020
3
66


Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Pei-Chi Chen, Su-Kiat Chua, Huei-Fong Hung, Chung-Yen Huang, Chiu-Mei Lin, Shih-Ming Lai, Yen-Ling Chen, Jun-Jack Cheng, Chiung-Zuan Chiu, Shih-Huang Lee,[...]. J Diabetes Investig 2014
20
16


Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients.
Eun Jung Kim, Myung Ho Jeong, Ju Han Kim, Tae Hoon Ahn, Ki Bae Seung, Dong Joo Oh, Hyo-Soo Kim, Hyeon Cheol Gwon, In Whan Seong, Kyung Kuk Hwang,[...]. Int J Cardiol 2017
38
16


Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
Qi Zhao, Ting-Yu Zhang, Yu-Jing Cheng, Yue Ma, Ying-Kai Xu, Jia-Qi Yang, Yu-Jie Zhou. Curr Vasc Pharmacol 2021
2
100



Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
8

Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction.
Wei Ren Chen, Feng Tian, Yun Dai Chen, Jing Wang, Jun Jie Yang, Zhi Feng Wang, Jin Da Wang, Qing Xiu Ning. Int J Cardiol 2016
21
8


Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
8

Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction.
Wei-Ren Chen, Xue-Qin Shen, Ying Zhang, Yun-Dai Chen, Shun-Ying Hu, Geng Qian, Jing Wang, Jun-Jie Yang, Zhi-Feng Wang, Feng Tian. Endocrine 2016
46
8

Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
Sebastiaan C A M Bekkers, Saami K Yazdani, Renu Virmani, Johannes Waltenberger. J Am Coll Cardiol 2010
176
8

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.
Ronen Jaffe, Thierry Charron, Geoffrey Puley, Alexander Dick, Bradley H Strauss. Circulation 2008
229
8

Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction.
Justin B Echouffo-Tcheugui, Dhaval Kolte, Sahil Khera, Herbert D Aronow, J Dawn Abbott, Deepak L Bhatt, Gregg C Fonarow. Am J Med 2018
12
8

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Tingcun Zhao, Pratik Parikh, Siva Bhashyam, Hakki Bolukoglu, Indu Poornima, You-Tang Shen, Richard P Shannon. J Pharmacol Exp Ther 2006
232
8




Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.
M Monami, I Dicembrini, C Nardini, I Fiordelli, E Mannucci. Diabetes Obes Metab 2014
117
8

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Dario Giugliano, Stefano Genovese. Diabetes Care 2013
115
8

Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents.
B B Dokken, L R La Bonte, G Davis-Gorman, M K Teachey, N Seaver, P F McDonagh. Horm Metab Res 2011
45
8

Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
Wei Ren Chen, Yun Dai Chen, Feng Tian, Na Yang, Liu Quan Cheng, Shun Ying Hu, Jing Wang, Jun Jie Yang, Shi Feng Wang, Xiao Fang Gu. Circ Cardiovasc Imaging 2016
50
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.